Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Intangibles: 2019-2025

Historic Change in Intangibles for Ptc Therapeutics (PTCT) over the last 7 years, with Sep 2025 value amounting to $252.8 million.

  • Ptc Therapeutics' Change in Intangibles rose 2364.89% to $252.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.0 million, marking a year-over-year increase of 133.80%. This contributed to the annual value of $67.7 million for FY2024, which is 26.51% down from last year.
  • Latest data reveals that Ptc Therapeutics reported Change in Intangibles of $252.8 million as of Q3 2025, which was up 9,341.54% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Change in Intangibles registered a high of $252.8 million during Q3 2025, and its lowest value of $808,000 during Q1 2025.
  • In the last 3 years, Ptc Therapeutics' Change in Intangibles had a median value of $17.9 million in 2023 and averaged $41.6 million.
  • Data for Ptc Therapeutics' Change in Intangibles shows a peak YoY increase of 2,364.89% (in 2025) and a maximum YoY decrease of 98.52% (in 2025) over the last 5 years.
  • Ptc Therapeutics' Change in Intangibles (Quarterly) stood at $15.3 million in 2021, then increased by 20.00% to $18.4 million in 2022, then increased by 24.60% to $22.9 million in 2023, then tumbled by 88.08% to $2.7 million in 2024, then soared by 2,364.89% to $252.8 million in 2025.
  • Its last three reported values are $252.8 million in Q3 2025, $2.7 million for Q2 2025, and $808,000 during Q1 2025.